PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report)’s share price traded down 1.9% during mid-day trading on Tuesday . The stock traded as low as $2.09 and last traded at $2.11. 7,640 shares changed hands during mid-day trading, a decline of 13% from the average session volume of 8,831 shares. The stock had previously closed at $2.15.
PharmaCyte Biotech Stock Performance
The stock’s 50-day moving average is $2.20 and its 200-day moving average is $2.19.
About PharmaCyte Biotech
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
Read More
- Five stocks we like better than PharmaCyte Biotech
- CD Calculator: Certificate of Deposit Calculator
- Garmin Navigates to New Highs Driven By Wearables Trend
- Using the MarketBeat Dividend Tax Calculator
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Invest in the FAANG Stocks
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
